In this Q&A, Berkeley Lab bioscientist Paul Adams, who leads the development of a widely used data analysis software, discusses structural biology’s role in vaccine and antiviral research. https://newscenter.lbl.gov/2021/03/15/qanda-molecular-imaging-covid19/
January 2019 – July 2022
